More about The Bombay Burmah Trading Corporation, Limited
Fundamentals for The Bombay Burmah Trading Corporation, Limited
Regulatory Filings for The Bombay Burmah Trading Corporation, Limited
Defence Profits Reach Dharavi's Machinists
From COVID Debt to Green Despair: Industrial Discharge Is Destroying India’s Last Prawn Nurseries
The Hidden Cost of India's Electronics Assembly Push: A 40% E-Waste Surge and the Death of Affordable Repair
The Wedding Loan Trap: How India’s Microfinance Boom Turned Housewives Into Ghost Borrowers and Temple Brass Into EMI Cash
Fundamentals for The Bombay Burmah Trading Corporation, Limited
Business Operations:
Sector: Consumer DefensiveIndustry: Packaged Foods
The Bombay Burmah Trading Corporation, Limited, together with its subsidiaries, engages in the tea and coffee plantations, auto electric components, healthcare, and real estate businesses in India and internationally. It operates through six segments: Plantation- Tea, Health Care, Auto Electric Components, Investments, Horticulture, Food -Bakery & Dairy Products, and Others. The company produces and trades in tea, coffee, timber, cardamom, and pepper; and manufactures and trades in dental products. It also manufactures solenoids, switches, valves, and slip rings for automobile and other industries; and invests in various listed and unlisted securities primarily on a long-term basis. In addition, the company manufactures and trades in analytical, precision balances, and weighing scales; and engages in the property development activities. Further, the company deals with decorative plants and landscaping services; and offers bakery and dairy products. The Bombay Burmah Trading Corporation, Limited was incorporated in 1863 and is based in Mumbai, India.
Revenue projections:
Financial Ratios:
| currentRatio | 0.000000 |
|---|---|
| forwardPE | 4.012048 |
| debtToEquity | 30.298000 |
| earningsGrowth | -0.067000 |
| revenueGrowth | 0.080000 |
| grossMargins | 0.418720 |
| operatingMargins | 0.182160 |
| trailingEps | 158.670000 |
| forwardEps | 373.500000 |
With both earnings and revenue growth in low territory, BBTC is likely to see shrinking profits. This signals a possible downturn in the company's financial health and may raise concerns about its future profitability.
BBTC's negative gross and operating margins reflect unprofitability, suggesting the company is unable to generate revenue sufficient to cover its costs. This could indicate deeper financial challenges or declining efficiency.
BBTC's forward EPS being higher than its trailing EPS suggests that the company is expected to generate stronger profits this year. This points to improving financial performance, with BBTC anticipated to deliver better earnings than it did in the prior year.
Recommendation changes over time:
Analysts' recent buy bias toward BBTC suggests the stock is gaining favor as a strong investment choice. This optimism could drive more investors to see BBTC as a smart place to invest, further bolstering confidence in the company's long-term growth and potential returns.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
From Lifesaving Drugs to Sick Units: The Hidden Energy Crisis Inside India’s Pharma Clusters
From Price Pressures to Profit Power: The MSME Playbook Redefining India’s Economy
₹90 Crore Bet Signals a Massive Shift in India’s Rural Economy